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ABSTRACT 
Pulmonary intravascular macrophages (PIMs) promote lung inflammation and are found 
in ruminants, horses, pigs, cats, and dolphins, but not in primates, rats and mice. Rabbits 
are used to study mechanisms of lung inflammation in humans, but disagreement exists 
whether rabbits have PIMs. This study examined rabbits for PIMs, and their influence on 
endotoxin-induced lung inflammation.  
Rabbits were treated with gadolinium chloride (10 mg/kg intravenous: Group GC, 
n=6) to produce apoptosis in PIMs, or with saline (Group SAL, n=6). Rabbits were 
euthanized 48 hours later. Light microscopic examination of epoxy-embedded rabbit lung 
sections revealed mononuclear phagocytes in alveolar septa.  Transmission electron 
microscopy confirmed PIMs with lysosomes and close attachment to capillary 
endothelium. Light microscopic immuno-cytochemistry using rabbit anti-macrophage 
antibody (RAM-11) showed staining of septal and alveolar macrophages. There was no 
difference in number of RAM-11 positive septal cells between SAL and GC rabbits 
(P=0.2). 
Rabbits were administered intravenous E.coli 0127:B8 endotoxin (100 µg/kg) 48 
hours after GC (GC-LPS; n=5) or SAL treatment (SAL-LPS; n=6), and euthanized 24 
hours later. Rabbits in both LPS treated groups were hypocalcaemic and exhibited 
compensated metabolic acidosis compared to SAL rabbits. Four rabbits died in the SAL-
LPS group within 24 hours of the endotoxin treatment and were replaced. None died in 
the GC-LPS group (Chi-square comparison for survival P=0.063). Greater numbers of 
septal heterophils were found in groups SAL-LPS and GC-LPS compared to SAL and 
GC. TNFα protein in serum, and IL-1β and IL-6 mRNA in lung tissues were increased in 
SAL-LPS compared to SAL and GC rabbits. Lung tissues from SAL-LPS rabbits but not 
in GC-LPS showed moderate inflammation, but lung wet/dry ratios were not different. 
Lung tissue TNFα, IL-1β and IL-6 mRNA, myeloperoxidase activity, and serum TNFα 
were reduced in GC-LPS animals compared to SAL-LPS. Immuno-electron microscopy 
revealed TNFα in PIMs in normal and LPS-treated rabbits. Lung and liver tissue TNFα, 
IL-8 and MCP-1 protein concentrations were not different between groups. GC did not 
appear to reduce liver inflammation. These data show that rabbits have low numbers of 
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PIMs. GC treatment induced apoptosis in PIMs and reduced endotoxin-induced lung 
inflammation and mortality. 
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INTRODUCTION 
1.1 Inflammation 
Inflammation is the response of the body to invasion of pathogens, antigens and/or 
physical or thermal injury. Not only does the response involve removing or rendering 
safe the body from invasion or injury, but also promotes healing and recovery. There are 
times however, when the pathogen invasion or injury overwhelms, and the inflammatory 
response is not sufficient to remove pathogens or provide repair. The inflammatory 
response itself can also overwhelm, and become detrimental to the body, for example, 
during sepsis or acute lung injury. Both situations can lead to the demise of the 
individual. Therefore, tight regulation of the inflammatory response tailored to the type of 
insult is important for a successful outcome. 
Although there is a great deal of overlap between events, the four stages are traditionally 
described as: 1) Destruction and removal of injurious agents; 2) Containment of the 
harmful agents; 3) Stimulation and amplification of the immune response and 4) 
Promotion of healing (Botting and Botting, 2000). Cells of the immune system are 
involved in this process. Macrophages are considered to be tissue sentinel cells which 
ingest invading pathogens, process antigens and are involved in antigen presentation to T 
and B lymphocytes. Neutrophils are recruited to the site of inflammation with release of 
chemoattractants (chemokines) and also ingest bacteria. Cytokines are used to 
communicate between cells and mediate the process of inflammation. Cytokines are 
considered to have pro- or anti- inflammatory functions, acting on the cells that produce 
them, and also on neighbouring cells (autocrine and paracrine actions). Endocrine actions 
are also important as cytokines are transported throughout the body using the circulatory 
system. Cytokines bind to cell surface receptors and initiate internal signalling pathways 
which then influence gene transcription. In this way, the inflammatory process is up- or 
down- regulated. For example, among many pro-inflammatory actions, tumour necrosis 
factor-α (TNF-α) can upregulate the production of nitric oxide (NO) causing 
vasodilatation, and interleukin (IL)-10 has anti-inflammatory actions by limiting the 
production of TNFα. The same cytokines can have different actions on different cells 
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with changing circumstances. Chemokines are responsible for attracting cells to the site 
of injury or inflammation and are produced by leukocytes and endothelial cells. Different 
chemokines can attract different cell types depending in their structure (Rankin, 2004). 
Relevant cytokines pertaining to monocyte, macrophage and neutrophil function and 
important to this work are described later. 
The start of the inflammatory process usually stems from cell injury. Vasodilatation is 
produced by released mediators from disrupted cells and leads to endothelial cell 
cytoskeleton changes, opening pores, and causing capillary leakage. Thromboxane A2 
causes platelet aggregation at the site of injury, which is part of tissue protection and 
healing. Exudation of fluid into the site of injury through leaky endothelium causes 
swelling and dilution of toxins, and provides a fluid environment for movement of 
immunoglobulins and leukocytes.  
Cells from the immune system are recruited from the circulation in order to assist in 
removal of pathogens and tissue debris. Margination of leukocytes along cytokine-
activated endothelial walls occurs through production of adhesion molecules (selectins, 
integrins). Both IL-1 and TNF-α stimulate production of selectins which mediate 
leukocyte capture (P or E-selectin on endothelium and L-selectin on leukocytes). 
Integrins are transmembrane glycoproteins that attach cells to extracellular matrix 
proteins of the basement membrane, ligands or other cells, and also initiate cell 
signalling. 
Captured leukocytes go through a transient and reversible rolling stage followed by a 
firmer, adhesive, slow rolling stage through CD18 integrins. Following this, migration of 
the leukocyte from blood vessel to tissue space occurs, a process called diapedesis. 
Neutrophils are not normally found in large numbers in tissue spaces. Transmigration, 
using chemotaxis, is important to recruit neutrophils to the point of injury or invasion. 
Within 24 hours of onset of inflammation, monocytes are also recruited and differentiate 
into macrophages. These cells clear dead neutrophils through CD31interactions, 
pathogens and cell debris, and initiate healing (Rankin, 2004). 
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1.2 Acute Lung Injury and Endotoxin 
Acute Lung Injury (ALI) and the more severe form, Acute Respiratory Distress syndrome 
(ARDs), result from direct lung damage, or as a result of indirect contact with endotoxin 
or cytokines originating elsewhere in the body. In humans, the condition is characterized 
by clinical features of: 1) acute onset; 2) bilateral alveolar infiltrates on radiograph with a 
normal left atrial blood pressure (noncardiogenic oedema); 3) increased alveolar-arterial 
partial pressure of oxygen gradient (PaO2/FIO2 ratio of <300mmHg for ALI and 
<200mmHg for ARDs) and 4) loss of lung compliance. The condition is increasingly 
recognized in veterinary medicine, and manifests as ‘equine neonatal respiratory distress 
syndrome’ and ‘vetALI/ARDs’ in dogs and cats (Wilkins et al., 2007). The systemic 
inflammatory reaction of sepsis results in multiple organ dysfunction and the lung may be 
included in the list of organs affected. ALI/ARDs from sepsis leads to high mortality in 
species with or without pulmonary intravascular macrophages (PIMs), but it appears the 
degree of lung injury is more intense when PIMs are present (Gill et al., 2008), 
(Parbhakar et al., 2005). The involvement of PIMs in ALI/ARDs is the subject of intense 
research using a variety of animal models.  
Lipopolysaccharide (LPS) is a glycolipid present in the outer cell wall of Gram-negative 
bacteria. LPS is composed of a lipid polar head group (Lipid A) and a chain of repeating 
disaccharides. Most of the observed response to LPS can be reproduced with lipid-A, but 
the disaccharide chain influences the magnitude of the response. LPS attaches to LPS-
binding protein and this combination stimulates CD14 (surface membrane receptor) on 
monocytes and macrophages, and to a lesser extent, neutrophils (Sabroe et al., 2005). 
Cell activation is mediated through the transmembrane protein Toll-like receptor 4 
(TLR4) (Beutler and Poltorak, 2001). Different TLRs respond to different pathogen 
components thus ensuring the correct process to deactivate the pathogen is produced. 
With surface protein MD2, the TLR4 cytoplasmic cell signalling pathway moves through 
MyD88, TRAF6, to IRAK where the pathway bifurcates.  One pathway produces IκB 
which produces the nucleus translocator, NFκB. The other pathway goes through MAP3 
kinase pathway to eventually produce NFκB. There are also links to other pathways 
including JNK/p38 which leads to apoptosis (programmed cell death) through caspase 
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mediators (Beutler and Poltorak, 2001). NFκB then activates the production of various 
messenger RNA proteins, stimulating the cell to produce other mediators. Intravenous 
LPS also activates capillary endothelium. It appears endothelial cells rapidly undergo 
apoptosis rather than necrosis from direct cell toxicity (Hack and Zeerleder, 2001).  
The initial phase of intravenous LPS results in leukopaenia, reduced cardiac output and 
fall in arterial blood pressure. Pulmonary arterial blood pressure can increase and this is 
observed more commonly in species with PIMs (Parkhabar et al., 2005), and is 
speculated to result from released thromboxane A2 and platelet-activating factor (Delong 
et al., 1999). An improvement in these signs occurs 4-6 hours following mild-moderate 
doses of injectable LPS, although in clinical situations the production of LPS may be 
ongoing and the signs may worsen.  
In presence of LPS, changes in lung compliance and hypoxaemia can be observed with 
increased alveolar-arterial oxygen partial pressure difference (decreasing PaO2/FIO2 
ratio) from increased shunt and widened diffusion barrier. Neutrophil trapping occurs in 
the pulmonary capillaries with intravenous (IV) or intra-alveolar administration of LPS. 
Very few neutrophils migrate into the alveoli when LPS is given intravenously, compared 
to intra-alveolar route administration of LPS (Reutershan and Ley, 2004), (Kuebler, 
2005). 
1.3  Cytokines and chemokines 
Pro-inflammatory cytokines include TNFα, IL-1α  IL-1β and IL-6. IL-1α is released 
from macrophages, endothelial cells and fibroblasts, and IL-1β is released from natural 
killer cells, macrophages and monocytes.  IL-6 is released from fibroblasts, endothelial 
cells, neutrophils, monocytes and eosinophils and has both pro- and anti-inflammatory 
actions. IL-10 is an anti-inflammatory cytokine for inhibition of cytokine production in 
monocytes. TNF-α is produced by monocytes, macrophages, T and B cells, fibroblasts, 
neutrophils, natural killer cells and endothelial cells. It has both paracrine and endocrine 
functions promoting inflammation and immune system functions. Transforming growth 
factor beta (TGF-β) is released from macrophages, lymphocytes and dendritic cells. 
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TGF-β has immunoregulatory functions and is chemotactic for leukocytes, although 
inhibits them once they are activated (Rankin, 2004). 
Chemokines are released to attract certain cells towards the site of injury. These are small 
proteins (8-10 kDa) and approximately 50 chemokines have so far been identified 
(Tizard, 2004). Nomenclature depends on spacing of cysteine residues, and IL-8 is now 
known as CXCL-8. IL-8 is produced by stimulated macrophages to attract and activate 
neutrophils. Monocyte chemotactic protein (MCP-1 or CCL-2) is produced by 
macrophages, T-cells, fibroblasts and endothelial cells to attract other monocytes to help 
with clearing debris and repair (Tizard, 2004). 
1.4 Macrophages 
Macrophages are part of the innate immune system (mononuclear phagocyte system) and 
act as sentinel cells, killing invading pathogens and play a role in triggering acquired 
immunity. Macrophages are specialized matured monocytes found in a number of tissues 
such as lymph nodes and bone marrow, serosa, connective tissue (histiocytes) and the 
spleen. Macrophages found in the circulation are discussed further below. Macrophages 
contain all the apparatus to manufacture and secrete cytokines once they have been 
activated (Tizard, 2004). Macrophages found in various organs differ in their function. 
Furthermore, macrophages found in the same organs also comprise a heterogenous 
population. In the lung, macrophages are found in the airways, alveoli, interstitium and 
the capillaries (Brain, 1992) 
1.4.1 Pulmonary Intravascular Macrophages (PIMs) 
PIMs are firmly adhered to the endothelial cells of blood vessels within the lungs (Brain, 
1992), (Longworth, 1997), (Staub, 1994), (Warner and Brain, 1990). These cells have the 
characteristics of mature tissue macrophages rather than monocytes, and form membrane 
adhesion complexes with endothelial cells (Longworth, 1997). PIMs are larger than 
monocytes (20-80µm) with more developed Golgi apparatus, rough endoplasmic 
reticulum and mitochondria. Their plasma membrane has a glycocalyx with 
micropinocytosis vermiformis indicating active endocytosis (Longworth, 1997). The 
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function of PIMs is rapid phagocytosis of invading bacteria, cellular debris, endotoxin 
and dying erythrocytes within the pulmonary circulation. Bacteria bind to the 
macrophage and stimulate the production of TNF-α and IL-1 which leads to activation of 
endothelium and expression of adhesion molecules leading to recruitment of neutrophils. 
The neutrophils then ingest the bacteria, undergo apoptosis, and are ingested by the 
macrophage thus preventing release of breakdown products into the circulation (Tizard, 
2004). PIMs also promote recruitment of platelets in lung microvessels (Singh et al., 
2004). The sequestered platelets contain IL-8 and may promote recruitment of 
neutrophils.  
Species in the order Artiodactyla naturally have PIMs and include pigs, deer, camelids, 
sheep, goats and cattle (Atwal et al., 1989), (Rybicka et al., 1974), (Staub, 1994), 
(Warner et al., 1986), (Winkler et al., 1985), (Winkler, 1988).  Species in the orders 
Perissodactyla (horse, burro) and Cetaceans (whales, dolphins) also possess PIMs (Brain 
et al., 1999), (Kawashima et al., 2004), (Parbhakar et al., 2005), (Staub, 1994). PIMs 
have also been identified in some strains of domestic cat (Molina and Brain, 2007), 
(Schneeberger-Keeley and Burger, 1970). Neonatal animals of PIM-positive species do 
not have PIMs at birth and recruit these cells within a few weeks (Horiguchi et al., 1996), 
(Warner et al., 1986). Species proven not to have PIMs can have the ability to recruit 
them with hepatic injury and include mice, rats, dogs and humans (Brain et al, 1999), 
(Gill et al., 2008), (Staub, 1994). 
It is unknown why some species have PIMs and others do not. The pulmonary circulation 
receives the entire cardiac output and PIMs are well positioned to thoroughly remove 
particles and back up the liver intravascular macrophage system (Warner et al., 1987), 
(Warner and Brain, 1990). The presence of PIMs does carry a price, and species with 
PIMs exhibit more severe acute lung injury (ALI) due to endotoxaemia, compared to 
species without PIMs (Chen et al., 2003), (Gill et al., 2008), (Parkhabar et al., 2005). 
Depletion of PIMs prior to endotoxin exposure can lessen the degree of ALI (Parbhakar 
et al., 2005), (Singh et al., 2004), (Gill et al., 2008), (Staub et al., 2001).  
Animal species with PIMs mount a more aggressive response to small doses of LPS in 
the µg/kg range. In contrast, species without PIMs require doses of LPS in the mg/kg 
range. (Frevert and Warner, 1992). However, upon recruitment of PIMs, rats become 
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highly sensitive to minute amounts of LPS and depletion of PIMs with gadolinium 
chloride reverts them to their original physiological phenotype (Gill et al., 2008). Rabbits 
appear to be intermediate in their response to LPS as doses of 100 µg/kg can be fatal 
(Ben-Shaul et al., 1999). 
1.4.2 Hepatic Küpffer Cells 
Macrophages in contact with the systemic circulation are also found in the liver (Küpffer 
cells) and spleen of all species, and are responsible for similar actions as PIMs.  Species 
with no PIMs rely heavily on Küpffer cells to clear blood of bacteria. Species with PIMs 
also have Küpffer cells, and the macrophage responsible for pathogen removal is 
probably more dependent on entry point of the invading pathogen, and which organ first 
receives the pathogen-laden blood (first pass effect) (Warner, 1996). Küpffer cells will 
also remove effete PIMs, or their released particles from the circulation (Molina and 
Brain, 2007). Küpffer cells are stimulated by LPS to produce pro-inflammatory cytokines 
(TNFα, IL-1, IL-6, IL-12), nitric oxide, reactive oxygen free radicals, and eicosanoid 
mediators. Normally, stimulation is at a very low level with normal amounts of bacterial 
translocation from the portal circulation. With high concentrations of LPS, a profound 
response is produced. Chemokines are also produced to attract neutrophils (Szabo et al., 
2002). The neutrophils can cause further liver injury through release of oxygen free 
radicals and proteases. Endothelial cells close to the Küpffer cells are also activated to 
release pro-inflammatory mediators and nitric oxide. These mediators contribute to 
changes in the microcirculation and refractory hypotension with ongoing LPS stimulation 
(Su, 2002). 
1.5 The Rabbit as a Model for Acute Lung Injury 
When using laboratory animal models it must be realized that different species have 
different mechanisms to deal with pathogen invasion. The rabbit has frequently been used 
to reflect human conditions including endotoxaemia, smoke inhalation, lung aspiration 
and positive pressure lung ventilation (Frevert et al., 2000), (Jesmin et al., 2004), 
(Altemeir et al., 2004), (Bidani et al., 1999). Some species have different Toll receptor 
pathogen/toxin recognition systems and the rabbit has 57% identity with human TLR4 
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receptors for LPS, compared with 48% observed with rat or mouse (Matute-Bello et al., 
2008). Rabbits also respond to LPS with similar intensity as humans, yet have more NO 
reactivity towards pathogens compared to humans. Because of the rabbit’s larger size, 
multiple blood sampling is possible, and systemic blood pressure can be measured using 
conventional equipment (Matute-Bello et al., 2008), (Poli-de-Figueiredo et al., 2008).  
There are conflicting and confusing reports as to whether rabbits possess PIMs. There are 
reports which indicate that PIMs are rarely found in comparison to species within the 
order Artiodactyla (Brain et al., 1999), (Horiguchi et al., 1996). There are also reports 
indicating PIMs are possibly present in rabbit lungs, and are capable of producing severe 
ALI. One study revealed the presence of irregularly shaped phagosomes containing 
electron dense material which corresponded to viral antiserum staining (Carrasco, 1991). 
In the rabbit, primary clearance of E. coli infusion from the bloodstream mainly occurs 
within the liver and spleen, and clearance values rise in the lung from 20% to 90% by 5 
hours post-infusion (Rogers, 1957). Another study found that primary clearance of LPS 
takes place in the liver, spleen and lungs, and the lungs contained the greatest 
concentration of Salmonella minnesota LPS five minutes post-infusion (Mathison and 
Ulevitch, 1979). The rabbit is frequently used as a model to study ALI and therefore the 
role of PIMs in the production of ALI needs to be addressed (Frevert et al., 2000), 
(Matute-Bello et al., 2008).   
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2 HYPOTHESIS 
a. Rabbits have pulmonary intravascular macrophages 
b. Eliminating pulmonary intravascular macrophages reduces lung inflammation 
with endotoxin challenge 
3 OBJECTIVES 
a. To establish the presence of pulmonary intravascular macrophages in the rabbit 
b. To understand the role of intravascular macrophages in endotoxaemia 
                                                                    10 
4.  RATIONALE 
Species containing PIMs are more prone to ALI when exposed to bacteria or endotoxin. 
It is known that ALI is reduced when PIMs have been previously removed using 
gadolinium chloride. There are many causes of ALI such as smoke inhalation, ventilator-
induced injury, endotoxin or pathogen invasion, and ALI can occur as a secondary 
problem to sepsis. The high mortality associated with ALI in all species makes it a 
priority to advance our knowledge and management of ALI. 
The rabbit is commonly used as a model to investigate ALI, but the presence of PIMs 
plays a strong role in the outcome. If it is found the rabbit has PIMs then this species 
could be used to reflect outcomes pertaining to horses. On the other hand, if the rabbit 
does not contain PIMs then its use as an appropriate model for humans is further 
validated.  
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5. MATERIALS AND METHODS 
Table 5.1. Reagents and their Sources 
Reagents Source 
Mouse anti-human antibody MAC387 AbD Serotec,  
Mouse anti-rabbit macrophage RAM 11 Dako Laboratories 
HRP-linked goat anti-mouse antibody BD Pharmaceuticals  
Sheep anti-human von Willibrand’s factor antibody The Binding Site, CA, USA 
HRP-linked donkey anti-sheep antibody The Binding Site, CA, USA 
Goat anti-rabbit TNF polyclonal capture antibody  BD Pharmingen 
Biotinylated mouse anti-rabbit TNF detection antibody BD Pharmingen 
Recombinent rabbit TNF-α (111.4 ng/mL) BD Pharmingen 
Protease inhibitor cocktail Sigma Co. 
Cetylthrimethylammonium chloride (CTAC) Sigma Co. 
3’, 5, 5’- tetramethylbenzidine hydrochoride Sigma Co. 
Gadolnium Chloride. Made to 1.0 mg/mL by a 
compounding pharmacy, WCVM 
Sigma Co. 
Endotoxin (E.coli 0127:B8). Made to1 mg/mL by 
compounding pharmacy, WCVM 
Sigma Co.  
Peroxidase colour development kit (immunostaining) Vector Laboratories, USA 
Methyl green Vector Laboratories, USA 
Prilocaine/Lidocaine cream (EMLA cream) Astra Pharmaceuticals 
0.9% intravenous saline Abbott Laboratories 
Pentobarbital Euthanasia Solution (240 mg/mL) Bimeda-MTC Animal 
Health Inc., 
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5.1 Animals 
The study was approved by the University of Saskatchewan Protocol Review Committee 
(protocol numbers 20040083 and 20060058) and young, adult purpose-bred New Zealand 
White rabbits (Charles River Laboratories, Canada) were housed in an area with a 12 
hour light/dark cycle, and environmental enrichment according to Canadian Council for 
Animal Care guidelines. Rabbits were housed in pairs or separated depending on 
temperament. They were acclimatized to handling, the treatment room and restraint 
device for 1 week before study. Twenty-seven rabbits were used for this study and were 
fed a laboratory chow with free access to water. Twelve rabbits were used in the first part 
of this study, and the remainder used in the second part. 
 
5.2 Experimental Design 
The study was divided into two parts (5.2.1 and 5.2.2). The first part of the study was to 
investigate the presence of PIMs in the lungs of normal rabbits, and after depletion using 
gadolinium chloride (GC) (Mizgerd et al., 1996). Twelve rabbits (2.3 ± 0.1 kg 
bodyweight [mean ± SD]) were used in the first part of the study, and divided equally 
into two groups. One group (n=6) received saline and another group (n=6) received GC, 
these groups are designated SAL and GC, respectively. Rabbits were randomly selected 
by paper draw to receive saline (SAL) or gadolinium chloride (GC). 
 
 5.2.1. Depletion of PIMs using GC 
Rabbits were weighed and had prilocaine/lidocaine cream applied to the external surface 
of their ears one hour before placement of an over-the-needle catheter in a marginal ear 
vein (24G, Insyte Catheter, Becton-Dickinson and Co., Franklin Lakes, NJ, USA) and in 
the auricular artery (22G Insyte Catheter, Becton-Dickinson and Co., Franklin Lakes, NJ, 
USA). To deplete PIMs, six rabbits were administered GC (10 mg/kg intravenous [IV]). 
As a control, 0.9% saline (10 mL/kg IV) was administered to six other rabbits. Infusions 
were administered through the venous catheter during a 20 minute period using a 
computerized syringe pump (Medfusion 2100, Medexinc., Duluth, GA, USA). Once the 
infusion was finished, rabbits had all catheters removed and were returned to their cages.  
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Forty-seven hours later, prilocaine/lidocaine cream was again applied to the ears. An hour 
later, 5 mL of blood was withdrawn from the auricular artery, and divided between tubes 
containing EDTA, or no coagulant. Euthanasia was performed using an overdose of 
pentobarbital (200mg/kg IV) administered through a marginal ear vein. Tissues were 
collected as described later. The saline group (SAL) was considered to be the control 
group for both parts of the study (no treatment). Collection of data, tissues and samples is 
explained later in section 5.2.3 – 5.3.5. 
 
Timeline for Part One: Removal of PIMs with Gadolinium Chloride 
 
 
5.2.2 Endotoxin Administration 
The second part of the study investigated the effect of removing PIMs on ALI after 
administration of LPS. Rabbits were pretreated with saline or GC before injection of LPS 
as described earlier, and groups designated SAL-LPS or GC-LPS, respectively. Rabbits 
were randomly divided into two groups according to paper draw for pretreatment and 
both groups received LPS injection.  
A total of fifteen rabbits (2.2 ± 0.2 kg bodyweight) were used in total for this part of the 
study. The aim was to obtain six rabbits in each group. Four SAL-LPS rabbits died within 
24 hours of administration of LPS and were replaced, one rabbit survived, leaving a final 
number of five rabbits in the SAL-LPS group. Six rabbits in the GC-LPS group survived 
to study completion. It was elected to not risk further loss of rabbits just to gain the final 
number of six rabbits in group SAL-LPS.  
At 48 hours after administration of either saline or GC, and one hour after desensitizing 
the ear using local anaesthetic cream, each rabbit had an arterial blood sample 
anaerobically withdrawn for blood gas analysis of baseline values. Following this, each 
rabbit received a bolus intravenous injection of 100 µg/kg of LPS (E.coli 0127:B8) 
(Jesmin et al., 2004). Rabbits were returned to their cages and frequently observed over 
the following 24 hours. At 24 hours post LPS injection, rabbits had their ears desensitized 
GC or saline 
infusion 
Wait 48 hrs 
EMLA 
cream 
Wait 1 hr 
 
EMLA 
cream 
Wait 1 hr 
Euthanasia 
and tissue 
processing 
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and arterial blood samples withdrawn, followed by humane euthanasia with an overdose 
of pentobarbital using a marginal ear vein. 
 
 Timeline for Part Two: Removal of PIMs and Administration of Endotoxin 
 
 
 
5.2.3 Systemic blood pressure measurement and blood sampling 
Direct systemic arterial blood pressure was measured during infusion of saline or GC 
during the first part of the study. Saline filled non-compliant tubing connected the arterial 
catheter to a calibrated silicon-chip transducer (Truwave Disposable Pressure Transducer, 
Baxter Healthcare Corporation, Edwards Critical Care Division, Irvine, CA, USA) 
leveled to the sternum of the rabbit, and zeroed to atmospheric pressure.  The transducer 
was connected to a physiological monitor (PB240 Operating Room Monitor, Puritan 
Bennet Corporation, Wilmington, MA, USA) displaying the systolic (SAP), mean (MAP) 
and diastolic (DAP) systemic arterial pressure. Arterial pressure measurements were 
recorded before infusion (baseline) and at five minute intervals during the 20 minute 
infusion period, and five minutes following termination of the infusion.  
Arterial blood gas samples were anaerobically withdrawn from the arterial catheter, 
placed on ice, and analyzed within one hour using a blood gas analyzer (Ciba-Corning 
238 blood gas analyzer, Ciba Corning Diagnostics, Halstead, Essex, UK). Blood 
electrolytes, glucose and lactate concentrations were also measured. Samples were 
withdrawn at baseline, after the infusion had finished, and 24 hours after LPS injection in 
the second part of the study. 
Alveolar – arterial (A-a) oxygen partial pressure difference was calculated using archival 
recordings of barometric pressure from the Environment Canada website: 
http://www.climate.weatheroffice.ec.gc.ca/climateData/hourlydata_e.html 
EMLA 
cream 
Wait 1 hr 
GC or Saline 
infusion 
Wait 48 hrs 
EMLA 
cream  
Wait 1 hr 
Inject LPS 
Wait 24 hrs 
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cream 
Wait 1 hr 
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The following equation was used: 
       PAO2 = ({Barometric pressure – 47} x 0.21) – (PaCO2 /0.8) 
Where PAO2 is partial pressure of O2 in the alveolus (mmHg) 
47 mmHg is saturated water vapour pressure at body temperature 
0.8 is the standard respiratory quotient 
0.21 represents the percentage of oxygen in room air, expressed as a decimal 
5.3 Sampling and Processing 
5.3.1. Collection of Tissues  
All samples were stored on ice until further processed. After opening the thoracic cavity, 
the right lung was ligated at the hilus to avoid lavage fluid entering the lung. The 
pulmonary circulation was flushed using a 16G hypodermic needle inserted into the right 
ventricle with an incision made in the left atrium. Phosphate buffer solution (PBS) 
containing ethylenediaminetetraacetic acid (EDTA) was used as perfusion fluid. At least 
100 mL was infused through the pulmonary circulation to remove erythrocytes and 
pulmonary monocytes. Following pulmonary circulation flush, a tracheotomy was 
performed distal to the larynx and a 6 Fr polyethylene feeding tube advanced to the level 
of the thoracic inlet to allow bronchoalveolar lavage (BAL). The tube was ligated with 
the trachea distal to the point of tracheal insertion. Lavage was performed three times by 
slowly infusing 10 mL PBS/EDTA through the feeding tube each time followed by 
aspiration. The first volume of BAL aspirate was kept separately from the last two 
flushes for future analyses. The caudal lobe of the right lung was removed, blotted of 
excess fluids and placed onto a pre-weighed tin foil dish. The remainder of the lung was 
placed into liquid nitrogen with the medial liver lobe and spleen. The frozen tissues were 
then placed into a -80oC freezer until required later for further analyses. The left lung was 
then perfused in situ with 2% paraformaldehyde, 0.1% gluteraldehyde in 0.1M sodium 
cacodylate buffer through the feeding tube using a hydrostatic pressure of 25 cmH2O, and 
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until fixative stopped flowing. The rabbit was suspended during lung infusion for 30 
minutes and the left lung was removed after this period.  
 
5.3.2. Lung and liver fixation and preparation  
The left lung was removed and placed into 2% paraformaldehyde, 0.1% gluteraldehyde in 
0.1M sodium cacodylate buffer. The caudal lobe of the left lung was divided into seven 
sections and slices 2, 4 and 6 taken for further examination. Slices were placed into 
cassettes and left in 4% paraformaldehyde for 24 hours at 4oC. The tissues were then 
washed three times in PBS and left in PBS at 4oC until required. A portion of the right 
liver lobe was also taken, slices placed into cassettes and the tissues treated in the same 
manner. For immuno-electron microscopy, the cranial lung lobe and a portion of the right 
liver lobe was divided into 1 mm3 cubes and placed in 2% paraformaldehyde, 0.1% 
gluteraldehyde in 0.1M sodium cacodylate buffer and after 3 hours, washed three times 
with 0.1M sodium cacodylate buffer, and left in this buffer solution at 4oC. Other 1mm3 
cubes were used for regular ultrastructure electron microscopy. These tissue pieces were 
placed into 2% paraformaldehyde; 2.5% gluteraldehyde in 0.1M sodium cacodylate 
buffer for three hours, washed in three changes of 0.1M sodium cacodylate buffer and 
kept in this buffer at 4oC. For light microscopy, the tissue pieces in cassettes were 
processed through ascending concentrations of ethanol into paraffin using a tissue 
processor. Tissues were then blocked so that a section of each slice of lung was in one 
paraffin block. Sections 5µm thick were placed onto silane-coated slides and stained with 
haematoxylin/eosin or used for immuno-histochemistry. 
 
5.3.3. Blood Samples  
Blood smears were made using EDTA blood, air-dried, fixed with chilled 1% acetone for 
three minutes and then left overnight, after which they were stained with Wright’s stain. 
Differentials were performed at a magnification of x100 by counting 100 cells using a 
crenallated pattern along the periphery and within the tail of the smear. A whole blood 
white cell count was performed after red cell lysis using a Neubauer haemocytometer and 
a commercial kit (Unopette Microcollection system, Becton Dickinson Vacutainer 
Systems, Becton Dickinson and Co., Franklin Lakes, NJ, USA). Coagulated blood 
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samples were left overnight at 4oC and centrifuged at 1400rpm for 15 minutes and the 
serum extracted. Serum was aliquoted into Eppendorf tubes and placed at -80oC. 
 
5.3.4. Analysis of BAL Fluid  
The fluid collected from BAL was centrifuged at 1500rpm for 10 minutes at 4oC and the 
supernatant from the first BAL flush aliquoted into Eppendorf tubes and placed at -80oC. 
The cell pellet was resuspended, and added to resuspended cell pellets from the 
remaining BAL flushes. Red cell lysis was performed by adding 9mL distilled water and 
18 seconds later, adding 1mL 10X PBS. White cell count was performed using a 
haemocytometer. The tubes were centrifuged once again and the supernatant discarded. 
The cell pellet was resuspended and diluted to the appropriate amount using PBS/EDTA 
solution. Cytospin was performed using 100 µL (105 cells/slide) of the solution at 1800 
rpm for five minutes. Slides were left to air-dry and were then fixed in chilled 1% 
acetone for three minutes, left overnight and then stained using Wright’s stain. 
Differentials were performed at a magnification of x100 by counting the cells within ten 
random fields. 
 
5.3.5 Wet/Dry Lung Ratio  
Lung pieces were weighed in foil and placed in an incubator at 68oC for seven days after 
which time the foil and lung was reweighed. The ratio was calculated by dividing the wet 
weight of the lung piece by the dry weight. The difference in weight was assumed to be 
water loss. 
 
5.4. Light Microscopy 
5.4.1. Haematoxylin/Eosin Stain  
Lung and liver tissue sections were stained using haematoxylin and eosin in a standard 
manner. Septal and alveolar heterophil (neutrophil) cells were counted in ten randomly 
selected fields at x100 power using light microscopy in lung tissue. Liver tissue was 
examined for infiltration of heterophils and a descriptive assessment made. 
 
                                                                    18 
5.4.2. Immunohistochemistry  
Slides of lung tissue were de-paraffinized with xylene and descending concentrations of 
ethanol. Endogenous hydrogen peroxide was removed using 0.5% hydrogen peroxide in 
methanol and antigen released using pepsin (2 mg/mL in 0.01N hydrogen chloride) at 
37oC. Slides were blocked using bovine serum albumin (1% BSA in PBS). Primary 
mouse anti-human antibody MAC-387 (1:25 dilution in BSA) (Flavell et al., 1987) and 
monoclonal mouse anti-rabbit macrophage RAM-11 (1:50 dilution in BSA) were used to 
identify pulmonary macrophages on separate sections of lung (100 µL/section) (Welt et 
al., 2000). After washing in PBS, secondary horse-radish peroxidase (HRP)-linked goat 
anti-mouse antibody (1:100 dilution in BSA) was applied for 30 minutes and then washed 
using PBS. Colour development was achieved using a commercial kit. Controls consisted 
of the same protocol except one section did not receive primary antibody, and another 
section received sheep anti-human von Willibrand’s factor antibody (1:250 dilution in 
BSA) with secondary antibody specific for this antibody (HRP donkey anti-sheep 
antibody; 1:150 dilution in BSA) (Kockx et al., 1993). Counter-staining was 
accomplished using methyl green. 
 
5.5 Immuno-Electron Microscopy 
Immuno-electron microscopy (IEM) was performed on tissues processed through several 
ascending concentrations of ethanol and into LR White resin (EM Sciences, USA) and 
resin hardened at -10oC with ultra-violet light for 48 hours. One micron sections were 
prepared and stained with toluidine blue to select appropriate areas for ultra-microtomy. 
Ultra-thin (0.1 micron) sections were cut from the tissue blocks and placed on nickel 
grids. 
Nickel grids with sections were floated on a blocking buffer (1% BSA and 0.1% Tween-
20 in tris-buffered saline; pH 7.9) for 30 minutes followed by incubation with rabbit 
TNF-α antibodies for one hour. Tissue sections were rinsed three times for five minutes 
each in Tris-buffered saline and incubated with appropriate gold conjugated secondary 
antibodies (1:100) for one hour followed by staining with 2% aqueous uranyl acetate and 
then lead citrate. 
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5.6  Myeloperoxidase Assay 
Samples of liver and lung were homogenized in 50 mM HEPES buffer solution at a pH of 
8.0 at a ratio of 200 mg tissue to 0.5 mL solution. Samples were centrifuged at 3,000 rpm 
for 20 minutes at 4oC and the supernatant discarded. The pellet was resuspended in 0.5% 
cetylthrimethylammonium chloride to the original volume. The sample was 
rehomogenized and centrifuged as before. The supernatant was removed for further 
analysis using a peroxidase colour substrate (TMB) and 1M sulphuric acid as stop 
solution. Samples of appropriate dilution using phosphate citrate buffer were placed in a 
standard 96 well plate. Baseline optical density was taken from wells with stop solution 
added before sample and TMB (time 0). Colour was allowed to develop in other wells for 
2 minutes before stop solution was added. All chemicals were used at room temperature. 
The optical density was measured using an optical reader at a wavelength of 450 nm. The 
density of the control (time 0) was subtracted from the sample reading (time 2 min), and 
this value used in statistical analysis (Schneider and Issekutz, 1996). 
5.7 Enzyme Linked Immunosorbant Assay (ELISA) 
ELISA was used to measure TNF-α protein concentrations in serum, BAL fluid, lung and 
liver tissue homogenate. Lung and liver tissues were homogenized in HBSS diluted with 
PBS solution containing protease inhibitor cocktail at a ratio of 100 µL cocktail to 10mL 
HBSS solution. Ratio of tissue to solution was 100 mg:1mL solution. Homogenates were 
centrifuged for 20 minutes at 3,000 rpm at 4oC.  The supernatant was collected and stored 
at -80oC until further analysis. Preliminary ELISA was performed to establish optimum 
concentrations of capture and detection antibodies. Capture antibodies were studied at a 
range 5 – 12.5 µg/mL (standard rabbit recombinant TNFα 0.5 ng/mL; detection antibody 
2.5 µg/mL). Detection antibody was tested at a range of 0.125 – 5.0 µg/mL (capture 
antibody 10 µg/mL; standard rabbit recombinant TNFα 0.5 ng/mL). Based on results, 10 
µg/mL capture antibody with 5 µg/mL detection antibody were selected for use in ELISA 
plates testing samples. 
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For ELISA of samples, 96-well plates were coated with 50 µL capture antibody (10 
µg/mL goat anti-rabbit TNF polyclonal antibody) diluted with sodium phosphate buffer, 
and incubated at 4oC overnight. Next day, excess capture antibody was removed and 100 
µL blocking buffer (1% BSA in PBS) was added to each well and incubated at room 
temperature for two hours. Blocking buffer was removed and wells were washed with 
PBST (PBS containing 0.05% Tween-20). Standard dilutions of recombinant rabbit TNF-
α (111.4 ng/mL; BD Pharmingen) at a range of 0.134 – 22 ng/mL in blocking buffer–
Tween were made. Standards and samples (100 µL of each) were added to the wells and 
incubated at 4oC overnight. After removing excess standards and samples, wells were 
washed with PBST and 100 µl of detection antibody (biotinylated mouse anti-rabbit TNF 
monoclonal antibody) were added to each well after dilution with blocking buffer-Tween. 
The plate was left at room temperature for 90 minutes. Excess detection antibody was 
removed and wells were thoroughly washed. Streptavidin-Horseradish peroxidase (100 
µL 1:5000 in 1% BSA/PBS) was added to each well and incubated for 90 minutes at 
room temperature. Wells were thoroughly washed with PBST and 100 µL TMB substrate 
(Substrate Reagent Pack, R&D Systems, Minneapolis, MN, USA) was added to each 
well, and incubated in the dark at room temperature for 30 minutes. The reaction was 
stopped at this time by adding 100 µL 2N sulphuric acid (Stop Solution, R&D Systems, 
Minneapolis, MN, USA) to each well. Optical density was measured using a microplate 
reader at a wavelength of 450 nm. Standard curves were created to calculate the 
concentration of TNF-α in sample wells. No cross-reactivity with other cytokines and 
10% cross-reactivity with mouse and human TNF are reported. The lower limit of 
detection was 0.18 ng/mL. 
Due to difficulties in obtaining commercial reagents for examination of rabbit tissues and 
fluids, another laboratory ran their established ELISA protocols for rabbits on BAL fluid, 
serum, and lung and liver tissue for MCP-1 (CCL-2) and IL-8 (CXCL-8) chemokines 
(Kajikawa et al., 1996). Lower limit of detection was 0.1 pg/mL for IL-8 and 0.16 ng/mL 
for MCP-1. 
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5.8 RT-PCR 
Total RNA was isolated from lung tissues by sequential extraction with TRIzol reagent 
(Invitrogen) followed by treatment with RNase-free DNase I (Qiagens) and purification 
by RNeasy mini-columns (Qiagens) according to manufacturer’s instructions. RNA was 
quantified by spectrophotometric analysis. 
Superscript III one-step RT-PCR system with platinum Taq DNA polymerase 
(Invitrogen) was used for semi-quantitative analysis of the levels of expression of TNF-α, 
IL-1β and IL-6 mRNA in lung and liver tissues of variously treated rabbits. Reactions 
were performed as directed by the manufacturer, using the oligonucleotide pairs in Table 
5.8. 
Each reaction was performed using 11.5ng/µL of total RNA and the thermocycler was 
programmed for reverse-transciptase at 55oC for three minutes, initial denaturation of the 
cDNA at 94oC for two minutes, 30 amplification cycles, each of which consisted of 94oC 
for 15 seconds, 59oC for 30 seconds, and 68oC for one minute followed by a final 
extension at 68oC for five minutes. To ensure lack of DNA contamination, two units of 
platinum Taq DNA polymerase was substituted for the Superscript III/RT/Platinum Taq 
mixture in the reaction. A negative control reaction consisted of all of the components of 
the reaction mixture except RNA. Amplified PCR products were electrophoresed on a 
1% TAE-agarose gel, stained with ethidium bromide and photographed under UV light. 
Table 5.8: Primer Sequences for Rabbit 
Gene Forward Primer Reverse Primer 
TNFα 5’-ATGGTCACCCTCAGATCA-3’ 5’- CTGAAGAGAACCTGGGAG-3’ 
IL-1β 5’-ATGGCAACAGTACCTGAG-3’ 5’-CGACTGACAAGACCTGCC-3’ 
IL-6 5’-ATGAACTCCTTCACAAGC-3’ 5’-CAGCTCCTTGATGGTCTC-3’ 
GAPDH 5’GGCAAAGTGGATGTTGTCGCC-3’ 5’GGGCACCAGCATCACCCCACT-3’ 
 
 
                                                                    22 
5.9   Statistical Analysis 
Data were assessed for Gaussian distribution by graphing and visual examination.  
Data from individual MPO and TNFα ELISA plates (3 tests) were analyzed using 
Kruskal-Wallis 1-way ANOVA followed by Dunn’s test. Once it was established that 
each of three MPO or TNFα ELISA plate tests were not different from each other and 
had normal distribution using graphing techniques for a particular fluid or tissue sample, 
data were pooled and re-analyzed using 1-way ANOVA followed by Bonferroni post-hoc 
test.   
A 2-way ANOVA for repeated measures with Bonferroni post-hoc test was used for 
systemic blood pressure, and saline or gadolinium chloride pre-infusion and post-infusion 
electrolytes, glucose and lactate, with time and treatment as factors. Wet/dry weight was 
examined using 1-way ANOVA with Bonferroni’s post-hoc test.  
White blood cell counts and differentials, slide cell counts, blood gases and pH,  
electrolytes, glucose, lactate, anion gap, A-a O2 difference, septal RAM-11 count, RT-
PCR data, serum TNFα, and IL-8 and MCP-1 data were compared using a Kruskal-
Wallis 1-way ANOVA followed by Dunn’s test, or a Mann-Whitney test for 
nonparametric data.  
A Chi-Square test was used to test whether pretreatment with gadolinium chloride had an 
influence on survival when given before LPS compared to saline pretreatment. 
All graphs and calculations were performed using computer software (GraphPad Prism 
4.02 for Windows, GraphPad Software, San Diego California USA, 
www.graphpad.com.). Significance was taken when P<0.05. 
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6 RESULTS 
6.1 Search for PIMs 
The following are the results from this study. 
a. There were no differences between the saline and the GC groups in the mean 
arterial blood pressure during infusion of saline and GC (Table 6.1.1) 
b. Arterial blood gases (Table 6.2.2), electrolytes, blood glucose and blood lactate 
concentrations (Table 6.1.1) were not different between SAL and GC. Potassium 
concentration was significantly lower in the SAL group after the saline infusion 
compared to before infusion, but remained within normal physiological limits.  
c. There were no differences in the total cell counts in the BAL fluid obtained from 
the SAL and the GC groups. All cells found were alveolar macrophages in both 
groups (Table 6.1.2). 
d. Lung sections stained with H&E showed normal lung architecture in samples 
obtained from both SAL and GC rabbits (Figure 6.1.1).  
e. Light microscopy on epoxy-embedded toluidine blue stained sections revealed 
macrophages in alveolar septum of lungs from both SAL and GC rabbits. In the 
lung sections from GC-treated rabbits, many septal cells with condensed nuclei 
were observed, as an indication of apoptosis (Figure 6.1.2:A and B).  
f. Routine electron microscopy revealed PIMs in the septal capillaries with 
characteristic close adherence to the endothelium, many lysosomes, and slightly 
indented nucleus (Figure 6.1.3: A, B and C).  
g. Immunohistology performed with anti-macrophage antibodies (MAC-387 and 
RAM-11) stained cells in the alveolar septa and within the alveoli (Figure 6.1.4: 
RAM-11: A and B).  
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h. The numerical counts of RAM-11 positive septal cells did not show any 
differences between the two groups (P=0.2; Figure 6.1.5).  
i. Lung tissue myeloperoxidase activity was not different between SAL and GC 
groups (Figure 6.2.5). 
6.2  Effects of Endotoxin (Part Two) 
6.2.1  Mortality 
Rabbits became visibly lethargic by two hours after injection of LPS. After injection of 
LPS, one out of six rabbits survived to 24 hours after LPS injection in group SAL-LPS 
and four of the five dead rabbits were replaced (SAL-LPS: n = 5) (Figure 6.2.1). In group 
GC-LPS, six out of six rabbits survived to 24 hours after LPS injection (n = 6). Chi-
square test found that rabbits receiving saline pretreatment were 3.5 times more likely to 
die, but P=0.063 and the curves were not significantly different. Withdrawal of blood was 
difficult in all rabbits after they had received LPS, compared to otherwise healthy rabbits 
and accounts for missing data in the LPS groups.  
6.2.2 Arterial Blood Gas Analysis, Electrolytes and Acid/Base Balance  
Blood gas sample data from groups SAL and GC from Part One of this study were used 
as controls to compare data from groups SAL-LPS and GC-LPS. Due to difficulties in 
obtaining blood samples from LPS treated rabbits, non-parametric statistics were used 
and data expressed as median (range) (Table 6.2.2). 
There was no differences in PaO2, Alveolar-arterial difference, pH, lactate, anion gap, 
sodium, chloride, ionised calcium and potassium ion concentrations, and base 
excess/deficit in GC-LPS or SAL-LPS groups compared to SAL or GC rabbits, or with 
each other.  
Bicarbonate ion concentrations and PaCO2 and were significantly lower in GC-LPS 
group rabbits compared to group SAL (Table 6.2.2).  
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6.2.3 Cell Counts and Histology  
The total blood leukocyte count was significantly lower in rabbits belonging to the SAL-
LPS group compared to the SAL control group from Part One of this study. There was no 
difference in white cell counts between other groups, or in the white blood cell 
differential (Table 6.2.3). 
There were no significant differences in total leukocyte counts in BAL fluid using a 
haemocytometer, or in macrophage numbers on cytospin, between any groups. With 
cytospin, one heterophil was observed in one rabbit from each SAL-LPS and GC-LPS 
groups (Table 6.1.2). 
There was no difference in number of septal heterophils between SAL-LPS and GC-LPS 
groups, and both LPS treated groups had greater numbers of septal heterophils compared 
to their respective control groups (Figure 6.2.3.1 and Figure 6.2.3.2: A, B and C).  
In H&E stained liver tissue there were a small number of heterophils infiltrating liver 
tissue in three GC-LPS rabbits.  In one rabbit from the SAL-LPS group the liver appeared 
hyperaemic with many heterophils (Figure 6.2.3.3: A and B).  
6.2.4 Wet/Dry Ratio of Lung Tissue 
There was no significant difference in water content of lung tissue between any groups 
(Table 6.2.4). 
6.2.5 Myeloperoxidase Assay  
It was established that data from three separate analyses did not differ therefore data from 
each analysis were pooled (Figure 6.2.5). Myeloperoxidase activity was significantly 
higher in lung tissue of rabbits in group SAL-LPS compared to group GC-LPS (P<0.05).  
6.2.6   ELISA for TNFα 
BAL fluid, liver and lung homogenate were tested three times using duplicate wells in 
each plate, and the data pooled for analysis once it was established each plate did not 
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differ from each other. Serum was tested twice as there was limited amount of material 
and nonparametric statistics used. Standard curves were of good quality on all plates. 
TNFα data is presented as mean ± SD. IL-8 and MCP-1 data were obtained from another 
laboratory using one test run (Kajikawa et al., 1996). 
6.2.6.1 Bronchoalveolar lavage (BAL) fluid TNFα, IL-8 and MCP-1 concentration 
There was a significantly higher concentration of TNFα in BAL fluid of rabbits in SAL 
control group compared to SAL-LPS and GC-LPS (Figure 6.2.6.1: A). Rabbits in the 
GC-LPS group had significantly lower TNFα concentrations compared to GC and SAL 
control rabbits. There were no differences between all treatment groups with IL-8 and 
MCP-1 concentration (Figure 6.2.6.1: B and C). 
6.2.6.2 Serum TNFα, IL-8 and MCP-1 concentration 
TNFα concentrations were found to be significantly higher in the serum of SAL-LPS 
rabbits compared to rabbits in group GC-LPS, GC and to SAL control (Figure 6.2.6.2: 
A). MCP-1 and IL-8 concentrations were not found to be significantly different between 
groups (Figure 6.2.6.2: B and C). 
6.2.6.3 Lung and Liver Tissue TNFα, IL-8 and MCP-1 concentration 
There were no significant differences in IL-8 concentrations in lungs or liver of rabbits 
between all groups (Figure 6.2.6.3: A and B). There were no significantly different MCP-
1 concentrations between all groups in lung or liver tissue (Figure 6.2.6.3: C and D). 
There were no significant differences in TNFα concentrations between all groups in lung 
and liver tissues (Figure 6.2.6.3: E and F). 
6.2.6.4   Immuno-electron microscopy for TNFα 
Immuno-electron microscopy revealed labeling for TNFα in PIMs of control and LPS 
rabbits. There appeared to be more gold particles observed in PIMs of LPS-treated rabbits 
(Figure 6.2.6.4: A and B).  
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6.2.7 RT-PCR 
6.2.7.1   Lung tissue TNF-α, IL-1β and IL-6 mRNA 
There was a significantly higher fold increase in TNFα (Figure 6.2.7.1), IL-1β (Figure 
6.2.7.2) and IL-6 mRNA (Figure 6.2.7.3) in lung tissue of SAL-LPS rabbits compared to 
GC-LPS rabbit lungs. There was a significant fold increase in IL-1β and IL-6 mRNA in 
SAL-LPS compared to SAL control rabbits.  
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Haemotoxylin and Eosin Staining and Immunohistology of Rabbit Lung Tissue: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.1: H&E staining of lung tissue from saline (A) and GC (B) pre-treated rabbit. 
AS represents Alveolar Space. Single arrows show Alveolar Septae, double arrow: 
alveolar macrophage. Original magnification: 10 (A) and 40 (B). 
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B 
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AS 
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Figure 6.1.2: Lung sections from a saline-treated (A) and gadolinium-treated rabbit (B) 
show healthy (A) and apoptotic (B) pulmonary intravascular macrophages (single 
arrows). AS: Alveolar Space. 
AS 
AS 
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B 
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Figure 6.1.3: Electron micrograph of a pulmonary intravascular macrophage (PIM) from 
septal lung capillaries of a rabbit from group SAL. The PIM contains a nucleus (N), and 
many lysosomes (L) and is attached to the capillary endothelium (E). EP: Epithelium; 
AS: Alveolar space. Original magification: 10,000 
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Figure 6.1.3: Figure B shows two apoptotic PIMs and C shows another apoptotic PIM 
with condensed nucleus (N) and apoptotic bodies (AB). Many vacuoles with digested 
material are also seen. E: Endothelium; SP: Alveolar Septum; AS: Alveolar Space. 
Original magnification: B: 4,500; C: 12,000. 
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Figure 6.1.4: Immunostaining with anti-macrophage antibody RAM-11 shows staining 
in alveolar macrophages (double arrows) and septal macrophages (single arrows). E: 
Endothelium. Original magnification: A: 40; B:100  
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Graph of RAM-11 septal macrophage count: 
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Figure 6.1.5: Graph of RAM-11 positive cell count in the alveolar septum of SAL and 
GC treated groups. Bars represent median values. 
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Table 6.1.1 of Mean Arterial Blood Pressure, Lactate, Glucose, Potassium and 
Ionized Calcium before, during and after Infusions (Part One) (Mean ± SD; n=6): 
Time 
(minutes) 
 
Mean Arterial 
Blood Pressure 
(mmHg) 
 
Glucose 
(mmol/L) 
 
Lactate 
(mmol/L) 
Electrolytes 
(mmol/L) 
Potassium Ionized 
Calcium 
 SAL GC SAL GC SAL GC SAL GC SAL GC 
Baseline  
(time 0) 
80± 9 80± 7 8.2±0.7 9.0±1.9 2.8±1.5 4.2±2.1 3.87±
0.11a 
3.77±
0.29 
1.67± 
0.06 
1.54± 
0.10 
5 75±10 78 ± 6 n/a n/a n/a n/a n/a n/a n/a n/a 
10 76±7 74±7 n/a n/a n/a n/a n/a n/a n/a n/a 
15 72±13 74±7 n/a n/a n/a n/a n/a n/a n/a n/a 
20 72±11 72±7 n/a n/a n/a n/a n/a n/a n/a n/a 
5 minutes 
after end 
of 
infusion 
74±11 76±7 8.6±0.9 8.6±1.8 2.0±0.7 2.8±1.3 3.30±
0.29a 
3.45±
0.44 
1.54± 
0.07 
1.46±
0.10 
n/a: Not available. Use of the same letter indicates significant difference from each other 
for that variable (P<0.05) 
 
 
Table 6.1.2 of Cell counts from Bronchoalveolar Lavage (BAL) (Mean ± SD): 
 
 Before LPS Injection 
Part One Study 
After LPS Injection 
Part Two Study 
Saline 
(n=6) 
GC 
(n=6) 
Saline 
(n=5) 
GC 
(n=6) 
BAL white cell count 
(105/mL) 
11.5 ± 6.5 15.4 ± 7.3 8.9 ± 4.1 11.1 ± 5.1 
Macrophage: Heterophil 
number 
(From 10 fields at x100) 
100:0 100:0 99:1 99:1 
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Table 6.2.2 of Arterial Blood Gases, Electrolytes and Acid Base (Median[range]): 
Variable  
Median (range) 
Pretreatment 
(Part One Study) 
24 hours after LPS injection 
 
SAL-LPS (n=3) 
 
GC-LPS (n=4) SAL (n=6) GC (n=6) 
PaO2 (mmHg) 79 (66-131) 82 (71-89) 114 (65-121) 93 (85-116) 
Alveolar-arterial O2 
Difference (mmHg) 
22 (0-35) 22 (18-37) 23 (14-52) 32 (23-42) 
PaCO2 (mmHg) 38 (34-41)a 36 (34-39) 25 (23-37) 27 (18-30)a 
Bicarbonate (mmol/L) 26 (24-31)a 25 (20-28) 17 (16-23) 18 (13-19)a 
pH (Units) 7.46  
(7.43-7.50) 
7.46  
(7.36-7.49) 
7.44  
(7.43-7.50) 
7.46  
(7.43-7.48) 
Base Excess/Deficit 
(Units) 
2.3  
(-0.2-7.0) 
1.7  
(-5.3-4.6) 
-3.9  
(-5.8-0.0) 
-3.9  
(-7.1- -2.4) 
Sodium (mmol/L) 137 (131-139) 138 (136-140) 141 (136-142) 140 (136-142) 
Chloride (mmol/L) 102 (99-104) 101 (99-103) 107 (102-113) 110 (98-112) 
Potassium (mmol/L) 3.8 (3.7-4.0) 3.7 (3.3-4.1) 3.7 (3.7-4.7) 3.8 (3.5-4.6) 
Ionised Calcium 
(mmol/L) 
1.6 (1.5-1.6) 1.5 (1.4-1.7) 1.3 (1.1-1.5) 1.3 (1.2-1.5) 
Glucose (mmol/L) 8.1 (6.8-9.1) 8.4 (6.7-13.2) 7.1 (6.9-7.6) 6.3 (5.5-7.4) 
Lactate (mmol/L) 2.0 (1.6-5.5) 4.3 (1.1-7.9) 3.5 (2.8-4.0) 3.3 (2.2-6.2) 
Anion Gap (mmol/L) 12.7  
(4.9-17.2) 
15.7  
(13.4-21.7) 
16.2 
(15.5-20.2) 
17.8 
(15.1-22.2) 
Unpaired samples. Use of the same letter indicates significant difference from each other 
for that variable (P<0.05). Some data in LPS groups missing due to difficulty obtaining 
blood samples.  
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Table 6.2.3 of Blood White Cell Count and Differential (Mean ± SD): 
 Normal 
Rabbit* 
Before LPS Injection 
Part One Study 
After LPS Injection 
Part Two Study 
Differential SAL (n=6) GC (n=6) SAL-LPS 
(n=3) 
GC-LPS 
(n=5) 
Blood WBC  (x 109/L) 5 - 12 6.7 ± 2.1 7.9 ± 1.0 5.0 ± 2.9 5.8± 3.5 
Blood Heterophil (%) 30 - 50 12.0 ± 7.4 20.0 ± 8.5 19.7 ± 8.5 18.8 ± 9.1 
Blood lymphocytes 
(%) 
30 - 60 78.0 ± 6.0 67.7 ± 8.0 73.0 ± 9.9 71.5 ± 7.0 
Blood Monocytes (%) 2 - 10 8.6 ± 1.7 10.3 ± 7.8 6.3 ± 5.5 8.0 ± 5.6 
Unpaired samples. Some data in LPS groups missing due to difficulty obtaining blood 
samples.  
* http://www.vet.uga.edu/vpp/clerk/lester/index.php. Accessed April 2009 
 
Table 6.2.4 of Lung Wet/Dry Ratios (Mean ± SD; n=6) 
Group SAL Group GC Group SAL-LPS Group GC-LPS 
5.4 ± 0.2 5.3 ± 0.2 5.2 ± 0.4 5.4 ± 1.0 
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Survival Curves: 
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Figure 6.2.1: Survival Curve after administration of LPS to rabbits either pretreated with 
saline or gadolinium chloride. Mortality recorded at timepoints 4, 12 and 24 hours after 
LPS injection. Rabbits receiving saline were 3.5 times more likely to die, but curves are 
not significantly different: P=0.063. 
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Septal Heterophil Counts:  
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Figure 6.2.3.1: Comparison of septal heterophil numbers in rabbits pretreated with either 
saline or GC and then administered LPS.  Bar represents median value. 
Same letter indicates significant difference between groups. 
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Figure 6.2.3.2: H&E staining of lung tissue from Saline (SAL) treated rabbit (A), SAL-
LPS treated rabbit (B), and GC-LPS treated rabbit (C). More septal heterophils are 
present in LPS treated rabbits. Arrows show macrophages and neutrophils. Original 
magnification: 10.
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Haematoxylin and Eosin Staining of Liver Tissue: 
 
 
Figure 6.2.3.3: H&E stain of liver tissue from saline (A) and GC treated rabbits (B) after 
receiving LPS. Note heterophil infiltration in liver of SAL-LPS rabbit. Original 
magnification: 10.
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B 
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Myeloperoxidase Assay from Lung Tissue: 
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Figure 6.2.5: Mean ± SD (n=6 each group) of myeloperoxidase concentrations in lung 
tissue from rabbits treated with either saline or GC with or without LPS. Pooled data 
from three analyses. 
a indicates significant difference from each other (P < 0.05) 
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ELISA Data: BAL Fluid; TNFα: 
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Figure 6.2.6.1: TNFα concentrations in BAL fluid (A) from control rabbit lungs and 
rabbits receiving LPS. Results from three analyses (mean ± SD). 
Same letter indicates significant difference between groups designated with that letter 
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ELISA Data: BAL Fluid; IL-8 and MCP 
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Figure 6.2.6.1: IL-8 (B) and MCP-1 concentrations in BAL fluid (C) from control rabbit 
lungs and from rabbits receiving LPS. Bars represent median values. No significant 
difference (Kruskall-Wallis test: B (P=0.2); C (P=0.024 before Dunn’s test)) 
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Serum TNFα concentration:  
A. 
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Figure 6.2.6.2: TNFα concentrations in serum (A) from control rabbits and rabbits 
receiving LPS. Bars represent mean values. Significant difference between groups SAL 
and SAL-LPS (P<0.001); GC and SAL-LPS (P<0.001); SAL-LPS and GC-LPS (P<0.05) 
(1-way ANOVA test with Bonferroni post-hoc correction).  
Same letter over a group indicates statistical difference from each other. 
 
 
 
 
 
 
 
 
 
                                                                    45 
Serum MCP-1 and IL-8 concentration: 
B. 
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Figure 6.2.6.2: MCP-1 (B) and IL-8 (C) concentrations in serum from control rabbits and 
rabbits receiving LPS. Bars represent median values. No significant difference. 
(Kruskall-Wallis test: B (P=0.1); C (P=0.6)) 
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Lung and Liver IL-8 concentration: 
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Figure 6.2.6.3: IL-8 concentrations in lung (A) and liver (B) tissue from control rabbits 
and rabbits receiving LPS. Bars represent median values. No statistical significance 
found (Kruskall-Wallis test: A (P=0.12; B (P=0.066)) 
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Lung and Liver MCP-1 concentration: 
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Figure 6.2.6.3: MCP-1 concentrations in lung (C) and liver (D) from control rabbits and 
rabbits receiving LPS. Bars represent median values. No statistical differences (Kruskall-
Wallis test: C (P=0.035 before Dunn’s test); D (P=0.18)) 
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Lung and Liver TNFα concentration: 
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Figure 6.2.6.3: TNFα concentrations (mean ± SD) in lung (E) and liver (F) from control 
rabbits and rabbits receiving LPS. Pooled data from three analyses. 
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Figure 6.2.7.1: RT-PCR data for TNFα mRNA in control rabbit lungs, and saline or  
pretreated and receiving LPS. Bars represent median values. 
 
 
 
 
 
 
Figure 6.2.6.4: Immunostaining for TNFα: Lung section from SAL (A) and SAL-LPS-
treated (B) rabbit show staining for TNFα (circles) in cytoplasm and nucleus (N) of 
PIMs. L: Lysosome; E: Endothelium; Ep: Epithelium; AS: Alveolar Space; Original 
magnification: 13000  
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RT-PCR Data: 
RT-PCR TNFα mRNA 
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Figure 6.2.7.1: RT-PCR data for TNFα mRNA in control rabbit lungs, and saline or GC 
pretreated and receiving LPS. Bars represent mean values. Statistical difference between 
SAL-LPS and GC (P<0.05) and between SAL-LPS and GC-LPS ((P<0.05) using 1-way 
ANOVA with Bonferroni post-hoc test. 
Same letter represents significant difference from each other (P<0.05) 
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RT-PCR IL-1β: 
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Figure 6.2.7.2: RT-PCR data for IL-1β mRNA in control rabbit lungs, and saline or GC 
pretreated and receiving LPS. Bars represent mean values. Statistical difference between 
groups SAL and SAL-LPS (P<0.001); GC and SAL-LPS (P<0.01) and SAL-LPS and 
GC-LPS (<0.01) using 1 way ANOVA with Bonferroni post-hoc test. 
Same letter represents significant difference from each other (P<0.05) 
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RT-PCR IL-6 : 
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Figure 6.2.7.3: RT-PCR data for IL-6 mRNA in control rabbits, and saline or GC 
pretreated rabbits receiving LPS. Bars represent mean values. Statistical difference 
between groups SAL and SAL-LPS (P<0.001); GC and SAL-LPS (P<0.001) and SAL-
LPS and GC-LPS (<0.001) using 1 way ANOVA with Bonferroni post-hoc test. 
Same letter represents significant difference from each other (P<0.05) 
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7.  DISCUSSION 
7.1 Search for PIMs in normal rabbit lung 
The microscopic data revealed PIMs in normal rabbits. Large mononuclear phagocytes in 
the lung septa of normal rabbits were observed with routine light microscopy on paraffin-
embedded and epoxy-embedded lung sections, and routine electron microscopy revealed 
intravascular macrophages attached to the lung capillary endothelium.  Taken together, 
these data demonstrate PIMs are present in normal rabbits. No morphometric 
comparisons were performed, so conclusions on the density of PIMs in the rabbit 
compared to sheep or horse is difficult. The relatively lower density of PIMs in rabbits 
and the dominance of Küpffer cells in particle removal may have led to earlier 
controversial conclusions that rabbits lack PIMs (Brain et al., 1999), (Horiguchi et al., 
1996). Identification of PIMs in this study may explain indirect evidence of PIMs in 
rabbit lungs of other reports (Carrasco, 1991). Humans are also reported not to have 
PIMs, but one report described their presence after examining normal parts of human 
lung from patients undergoing thoracotomy for noninfectious disease (Dehring and 
Wismar, 1989). Morphometric analysis was not performed to quantify PIM numbers, but 
Dehring and Wismer comment the density was lower than in sheep and pig lungs. It 
could be argued we were also observing monocytes normally present in the pulmonary 
circulation. Unlike Dehring & Wismar’s study, we attempted to remove loosely bound 
monocytes during flushing of the pulmonary circulation after euthanasia, leaving tightly 
adhered PIMs. Furthermore, electron microscopy showed that the cells in question had 
ultrastructural features of macrophages and not of monocytes. Taken together, the data 
reveal PIMs in rabbits. 
To determine presence of PIMs, the cells were depleted using GC in six rabbits. The final 
PIM count was compared between normal and GC-treated rabbits. Using electron 
microscopy, many apoptotic PIMs were observed, but there was no statistical decline in 
the numbers of PIMs in GC-treated rabbits (P=0.2). The numbers of PIMs in GC-treated 
rabbits may have been over-estimated because even the dysfunctional apoptotic PIMs 
would have still reacted with RAM-11 antibody as apoptotic cells maintain intact 
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membranes and their proteins. There is a species difference in the effect of GC on PIM 
numbers. Calves and horses treated with GC demonstrate significant reduction in PIM 
numbers at 48 hours and 72 hours, respectively (Singh et al., 2004), (Parkhabar et al., 
2005). Therefore, it is possible that PIM numbers in GC-treated rabbits would have 
declined significantly at later time points. Nevertheless, some GC-mediated reduction in 
PIM numbers supports presence of PIMs in normal rabbits. 
7.2 Impact of PIMs on endotoxin-induced inflammation  
Blood sampling was difficult after injection of LPS because the rabbits were clinically 
debilitated. Mortality was increased in the SAL-LPS group. It appeared GC had a 
protective effect probably through limitation of inflammatory mediator release (TNFα, 
IL-1β and IL-6), and prevention of high concentrations of toxic breakdown by-products 
from neutrophil (heterophil) phagocytosis (Hildebrand et al., 2006). Systemic 
inflammatory response and high mortality has recently been reported in a rat model of 
PIM recruitment, and treatment with GC before infusion of endotoxin reduced lung 
inflammation, and inhibited mortality (Gill et al., 2008). No post-mortem results were 
available, but circulatory collapse and coagulopathies from the inflammatory cascade 
could have led to death in SAL-LPS rabbits. Death from ALI appeared unlikely as 
surviving rabbits did not have severe ALI, although the lungs were not examined around 
the time death occurred (4-12 hours after LPS injection)   
7.2.1 Effects on blood cells and metabolites 
Intravenously injected LPS (250 µg/kg) in rabbits is rapidly removed from the circulation 
by the liver, spleen and lung, with a calculated elimination half-life of 12 hours 
(Mathison and Ulevitch 1979).  Endotoxin treatment also causes a significant reduction in 
peripheral total leukocyte numbers because of cells trapped in organs such as liver and 
lung (Reutershan and Ley, 2004), also observed in the current study. There appeared to 
be a reduction in white cell count in the SAL-LPS group compared to groups SAL and 
GC, but there was no statistical difference. A reduction in blood heterophil number 
between groups was not obvious, although LPS causes heterophil reduction (Cöl et al., 
2005). 
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The LPS-treated rabbits developed a prominent fully-compensated metabolic acidosis 
similar to a previous report at 10 hours after the same dose of LPS (Jesmin et al., 2004). 
Stabilization of plasma pH within normal limits occurred through increased minute 
ventilation and lowered PaCO2 and was also found in Jesmin et al’s study. During sepsis, 
excessive hydrogen ions (metabolic acidosis) arise from poor oxygen delivery to cells 
and lactate production (Jesmin et al., 2004). Stress hyperlactaemia also occurs from the 
respiratory burst in activated phagocytic cells (Mizock, 2000). Lactate was found to be 
elevated in all groups in our study, with no differences between groups. Normal lactate 
concentration in dogs and cats is <2.0 mmol/L, and this is probably true for rabbits (Pang 
and Boysen, 2007). It is unknown why control rabbits had high concentrations of lactate. 
Stress of handling has been shown to increase lactate concentrations in stress-susceptible 
pigs, and restraint may have increased lactate levels in all rabbits, including the SAL and 
GC control groups, despite attempts made to accustom rabbits to their test surroundings 
(Spencer, 1994). The rabbits receiving LPS tended to have higher chloride ion 
concentration. As anion gap and potassium concentration did not change appreciably 
between groups, the increased chloride may be due to early renal failure or circulating 
volume contraction (Koch and Taylor, 1992). Renal failure can contribute to the observed 
metabolic acidosis, but like lactate, increases anion gap due to retained sulphates and 
phosphates (Koch and Taylor, 1992). 
Glucose and calcium ion concentrations tended to decrease in both groups receiving LPS 
compared to control. This response is typical of endotoxaemia and has been previously 
reported (Aderka et al., 1987). Hypocalcaemia during sepsis is found in humans, horses, 
rats and pigs (Holowaychuk and Martin, 2007). Decrease in ionized calcium may be 
multi-factorial, and includes: parathyroid hormone imbalance, increased urinary loss of 
calcium, calcium chelation, tissue or cellular accumulation of calcium, 
hypomagnesaemia, and elevations in calcitonin precursors (Holowaychuk and Martin, 
2007). Hepatic dysfunction during endotoxaemia leads to impaired glucose release and 
hypoglycaemia, complicated by a cytokine-induced increased peripheral glucose uptake 
into cells, especially within macrophages and neutrophils (Mizock et al., 2000). 
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Serum TNFα concentrations in response to LPS challenge were higher in rabbits of the 
SAL-LPS group compared to the SAL, GC and GC-LPS groups. TNF-α levels have been 
found to peak at three hours after injection of LPS and remained elevated up to 10 hours 
post-LPS (Jesmin et al., 2004). Another study revealed peak TNFα concentrations at two 
hours after 100 µg/kg intravenous LPS, and levels declined to below detection by their 
last six hour sampling time-point (Rodriguez-Wilhemi et al., 2003). There are very few 
reports documenting the concentrations of serum or plasma cytokines at 24 hours after 
LPS injection. TNFα concentration at 24 hours after 1 µg/kg LPS was found to be within 
detectable limits, and approximated 10% of the concentration obtained at the three hour 
time-point (Arras et al., 1996). Therefore, it is feasible that TNFα concentrations could 
still be detectable at 24 hours after LPS, especially as a higher dose was used. As 
occurred with this study, removal of intravascular macrophages including PIMs by GC 
has been shown to reduce TNFα concentrations in the circulation after LPS challenge in 
other species (Gong et al., 2002). 
Serum IL-8 concentrations were not found to be different between groups, but the 
statistical analysis was complicated by the presence of only one value in the SAL-LPS 
group because of limited sample. Plasma IL-8 concentrations have been found to increase 
early after LPS injection and were elevated at 6 hours after injection of the same dose of 
LPS (Rodriguez-Wilhemi et al., 2003). It appears IL-8 and heterophil attraction is 
important for the production of MCP-1 (Miyazaki et al., 2000). It might be expected that 
MCP-1 concentrations would remain high at 24 hours after LPS injection as the 
inflammation moves into resolution phase characterized by the recruitment of monocytes. 
This increase was observed in our study, but only in GC-LPS rabbits. Lack of samples 
was probably a factor in accurate assessment of conditions in the SAL-LPS group. MCP-
1 can also be secreted by hepatic stellate cells in response to LPS, and may have been the 
source of MCP-1 in intravascular macrophage depleted rabbits (Ramadori et al., 2008). 
7.2.2 Effects of LPS on the Lung 
Injection of LPS did not cause severe ALI in these rabbits compared to previous reports 
using 100 or 500 µg/kg intravenous LPS with euthanasia at 10 and 8 hours, respectively 
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(Jesmin et al., 2004), (Zhijun et al., 2003).  The different sampling times make direct 
comparisons between studies difficult. We chose to euthanize the rabbits at 24 hours after 
LPS injection to assess survival over a longer term. A decrease in PaO2 at 10 hours after 
LPS injection is reported elsewhere, whereas PaO2 in our LPS treated rabbits increased 
slightly (Jesmin et al., 2004). PaO2 may have been enhanced by increased alveolar O2 
levels produced by hyperventilation and lowered alveolar CO2 levels. A more accurate 
examination of oxygenation using A-a O2 difference also found no changes. However, 
conclusions are difficult to draw as there were few arterial blood samples available in 
each of the GC-LPS and SAL-LPS groups. Examination of the wet/dry ratio did not 
reveal any differences between groups indicating that lung oedema was not prominent in 
our model, however a complicating factor may be the use of lung perfusion and retention 
of water within capillaries. Increases in wet/dry ratio at 10 hours after LPS injection have 
been reported along with increased movement of radio-labelled albumin into the alveoli 
(Jesmin et al., 2004). Further examination of histological sections of lung and liver by a 
pathologist blinded to treatment group would have further strengthened the study. 
White cell count and differential in BAL fluid cytospin was not statistically different 
between any groups. No migration of heterophils into the alveolar space was observed 
despite higher concentrations of IL-8 in BAL fluid of group SAL-LPS. The septal 
heterophil count was not different between groups receiving LPS, but significantly higher 
than found in lung septae of normal rabbits. Interestingly, the MPO assay revealed more 
activated heterophils in the SAL-LPS rabbit lungs compared to GC-LPS lungs. 
Neutrophil (heterophil) recruitment is a complex process which involves cytokine-
induced activation of vascular endothelium and expression of adhesion molecules such as 
selectins and integrins ((Kuebler , 2005). The role of cytokines such as TNFα, IL-1β and 
IL-6, which are involved in the early phase of acute lung inflammation, is highly 
important in starting the process of leukocyte recruitment. GC treatment before LPS 
infusion especially reduced the concentrations of IL-8 and MCP-1 protein, as well as, 
TNFα, IL-1β and IL-6 mRNA in lung tissue and BAL fluid compared to SAL-LPS 
rabbits. The lung endothelium of the GC-LPS rabbits may be less activated compared to 
endothelium in the SAL-LPS group, possibly through removal of local stimulatory 
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sources such as PIMs. Lung injury and MPO activity were reduced in an ischaemia-
reperfusion isolated rabbit lung model after removal of alveolar macrophages with GC 
(Gazoni et al., 2007). The removal of alveolar macrophages reported in that study 
conflicts with evidence that intravenous administration of GC only affects intravascular 
macrophages (Hildebrand et al., 2006), (Singh and de la Concha-Bermejillo, 1998). It is 
possible Gazoni et al were removing PIMs from their isolated rabbit lungs and not 
alveolar macrophages.  
A recent study performed in rabbits removed intravascular macrophages using liposome 
encapsulated clodronate, and were then administered Pneumococcus aeruginosa via the 
trachea (Kurahashi et al., 2009). The study proved loss of macrophages through 
examination of carbon particle uptake by the liver and spleen. The study did not examine 
carbon particle uptake in the lungs therefore the contribution of PIMs was not known. 
That study did find however, similar to our study, that only intravascular macrophages 
were removed as there was no difference in RAM-11 positive alveolar cells between 
depleted rabbits and control group (Kurahashi et al., 2009). Using this bacterial model of 
lung injury, depletion of macrophages resulted in more lung injury. This may be a result 
of uncontrolled bacterial invasion within the lungs and movement of bacteria into the 
circulation, whereas our model used intravenous endotoxin. Presence of PIMs in these 
two scenarios could explain the different results observed.  
Elimination of other intravenous macrophages such as Küpffer cells by GC has been 
found to reduce lung injury in a rat model which normally do not have PIMs (Okutan et 
al., 2004), (Tullis et al., 1996). Removal of other intravascular macrophages could 
explain reduced lung injury in our study, although removal of the Küpffer cells did not 
appear to reduce liver injury in our model. Subjective evaluation of liver tissues in this 
study showed lack of effect of GC on Küpffer cells. Although we cannot prove with our 
data, PIMs could have predominantly been affected by GC in our rabbits by removing 
GC during its first pass through the lungs with administration using a marginal ear vein. 
It has been previously reported that GC mainly depletes PIMs, and not Küpffer cells, 
when administered through a jugular vein in calves with PIMs (Singh et al., 2004), 
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although other groups have found that GC can still remove Küpffer cells in other species 
(Szabo et al., 2002).  
Mathison and Ulevitch (1979) examined the effects of LPS (E.coli O111:B4 LPS) and 
LPS (Salmonella minnesota R595), and found the former LPS type produced some 
accumulation of monocytes and neutrophils within the lung, but the R595 form produced 
high concentrations of these cells heavily labelled with LPS within five minutes of 
injection. Therefore, the final effect of intravascular macrophages and LPS on ALI can 
also depend on the type of LPS used, as well as dose used and route of administration of 
LPS, and choice of examination time-point. Increased MCP-1 concentrations in serum 
and lung tissue in LPS treated rabbits could have attracted more monocytes/macrophages 
to the pulmonary circulation by 24 hours after LPS injection (Ohgami et al., 1992). The 
pulmonary circulation was thoroughly flushed during lung tissue collection and loosely 
bound monocytes should have been removed. 
The high TNFα concentrations found in BAL fluid, lung and liver tissue of normal 
rabbits is difficult to explain. Concentration of TNFα in normal individuals is usually 
below detectable values (Arras et al., 1996). From examination of ELISA technique, it 
did not appear this source of error was the cause. Long-term storage may have had an 
effect on TNFα concentrations. The samples had been stored for three years at -80oC 
before analysis. Using a mathematical model, 90% recovery of TNFα protein is possible 
when samples are stored at -70oC for up to five years (Ruiz et al., 1996). It appears 
logical that TNFα concentrations should slowly decrease over time at low temperatures, 
and not increase. No studies were found which examined TNFα stability with other 
tissues or fluids at -80oC for as long as three years. Other investigators have examined 
whole and separated blood, and found TNFα concentrations can increase by 9.6% if 
incorrect handling of blood samples is used, and IL-6 can decrease by 14.3% (Flower et 
al., 2000).  TNFα concentrations can also increase by 17% with three freeze-thaw cycles 
(Flower et al., 2000). EDTA was found to be the most stable anticoagulant for use with 
cytokine studies, and was used in our study (Flower et al., 2000). The rabbits were all 
handled one hour before study procedures to apply EMLA (prilocaine/lidocaine) cream to 
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their ears. Restraint has been found to decrease TNFα concentrations by increasing IL-6 
levels, and lidocaine decreases TNFα concentrations, therefore these procedures do not 
explain the results found (Hale et al., 2003), (Mikawa et al., 1994). 
It is also expected to find low TNFα concentrations in lung lavage fluid of rabbits 
receiving IV LPS because the alveolar epithelial and capillary endothelium acts as a 
barrier compartmentalizing cytokines, and directing the inflammatory response to the 
correct area (Kuebler, 2005). In isolated lung preparations, LPS in perfusate has been 
found to increase lung lavage TNFα concentration in a time-dependent manner, and 
levels increased to 0.6 ng/mL by three hours, but were less than 15% of the perfusate 
TNFα concentration (Ghofrani et al., 1996). In our study, BAL TNFα concentrations are 
very similar to the serum TNFα concentrations in rabbits of the same group. Ghofrani et 
al (1996) used lower doses of LPS compared to our study and this may account for their 
lower concentrations of TNFα in lung lavage fluid and different time-points were used. 
The study was also performed in an isolated lung preparation and the perfusate did not 
contain neutrophils which are important in ALI (Ghofrani et al., 1996). Alveolar 
macrophages are a potential source of TNFα (Laskin et al., 2001), but it is unclear how 
these isolated cells would become activated by IV LPS. There was no evidence of 
capillary leak in our study, and heterophils were not observed in BAL cytospin 
preparations. In intact rabbits, it was found that TNFα and IL-8 concentrations increased 
in lavage fluid at eight hours following injection of a high dose (500 µg/kg) of IV LPS, 
but there was strong evidence of capillary leak in that study (Zhijun et al., 2003). Very 
high doses of IV LPS (5 mg/kg) in rabbits produced high mortality within six hours, and 
movement of heterophils into the alveolar space with high concentrations of IL-8 in BAL 
fluid (Kwak et al., 2004). Compartmentalization of the effects of intratracheal or IV LPS 
does not appear to hold true when high doses of LPS are used, and there is breakdown of 
the alveolar-capillary barrier. 
7.2.3 Effects of LPS on the Liver 
After euthanasia, in all rabbits receiving LPS, gross examination revealed the liver to be 
light coloured and swollen. Histological examination revealed heterophil infiltration in 
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both groups receiving LPS. The liver contains the largest mass of intravascular 
macrophages in most species, and this is probably true of rabbits since the number of 
PIMs is limited. Therefore activation of these macrophages can have endocrine effects on 
the rest of the body through release of cytokines and other inflammatory mediators 
(Szabo et al., 2002). In rabbits, LPS localizes in Küpffer cells after injection (Mathison 
and Ulevitch, 1979). In rats, when Küpffer cells are blocked by GC, the hepatocytes 
remove endotoxin (Szabo et al., 2002). The excretion of LPS then occurs through bile 
which completely inactivates endotoxin. Otherwise, removal of LPS is facilitated through 
LPS binding proteins and formation of high and low density micelles (Szabo et al., 
2002). In rats without PIMs, it has also been found that removal of Küpffer cells will 
increase ALI and increase inflammatory mediators, but this was not found to be the case 
in our rabbits (Kono et al., 2008). In our study, removal or block of intravascular 
macrophages decreased mortality from LPS injection. Redirection of LPS through 
hepatocytes, and the reduction in large quantities of inflammmatory mediators produced 
from Küpffer cells could have reduced the remote detrimental effects leading to 
haemodynamic instability and death. IL-8 can be produced by hepatocytes in place of 
Küpffer cells, and may explain a higher concentration of IL-8 in the liver of one GC-LPS 
rabbit (Ramadori et al., 2008). As discussed earlier the reduced mortality, expression of 
inflammatory mediators and accumulation of neutrophils (heterophils) in the lung may 
largely be due to the effect of GC on PIMs, and not indirectly inhibition of Küpffer cells 
and their remote actions on the lungs (Singh and de la Concha-Bertejillo, 1998).  
The liver appeared to contain high concentrations of TNFα, but there were no differences 
between groups. It appeared GC did not moderate TNFα production in the liver. IL-8 was 
also elevated in one rabbit of the GC-LPS group, and neutrophils were found within the 
liver on histological examination in both groups. MCP-1 concentrations in the liver were 
also similar between groups receiving LPS. Further examinations of the liver such as 
MPO assay, liver RT-PCR of pro-inflammatory cytokines, and wet/dry ratios may have 
helped to clarify whether GC had a liver-sparing effect. Examination of existing data 
indicates GC did not appear to protect the liver in these rabbits. 
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GC is a potent inhibitor of macrophage phagocytosis and induces apoptosis of these cells 
by blocking K-type Ca2+ channels, and competing with membrane calcium since their 
radii are similar (Palasz and Czekaj, 2000). It is also a cytochrome p450 inhibitor and can 
reduce the production of toxic free radicals, possibly through a paradoxical increase in 
TNF and IL-6 production, or decreased IL-4 production. Its affects are predominantly on 
intravascular macrophages, and does not appear to affect alveolar and splenic 
macrophages (Hildebrand et al., 2006). 
Damage to various organs can also be altered depending on point of entry of LPS into the 
body. If the liver receives the bulk of the LPS as first pass, it will remove the LPS and 
spare other organs such as the lung (Shimada et al., 2006). The rabbits in this study 
received LPS through a marginal ear vein and this avoids the hepatic first pass effect.  
8. CONCLUSIONS 
It appears that rabbits do contain a few PIMs and could be considered intermediate 
between species with no confirmed PIMs such as rats, and those that obviously have 
these cells such as horses. Elimination of other intravenous macrophages such as Küpffer 
cells did not appear to have an effect on liver injury, probably as hepatocytes dealt with 
LPS removal and produced cytokines. Removal of PIMs appeared to reduce ALI in the 
rabbit. 
9. PROPOSED FUTURE RESEARCH 
It was hoped that the rabbit could be used as a convenient model for research into equine 
ALI and the effects of treatments such as inhaled anaesthetics, however this model is not 
an appropriate reflection of the equine lung, and another model such as the ovine species 
may be more suitable.  
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